AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $521,000 | -64.4% | 11,300 | -57.5% | 0.00% | -60.0% |
| Q2 2021 | $1,465,000 | +100.1% | 26,600 | +27.1% | 0.01% | +66.7% |
| Q3 2020 | $732,000 | +308.9% | 20,931 | +883.1% | 0.00% | +200.0% |
| Q2 2018 | $179,000 | -81.4% | 2,129 | -79.1% | 0.00% | -75.0% |
| Q1 2015 | $961,000 | -18.3% | 10,200 | -2.9% | 0.00% | -20.0% |
| Q4 2014 | $1,176,000 | -29.5% | 10,500 | -61.4% | 0.01% | +25.0% |
| Q3 2014 | $1,668,000 | – | 27,200 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2013 | $67,000 | -23.0% | 2,800 | -9.7% | 0.00% | – |
| Q3 2013 | $87,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |